Developments Scholar Rock gets FDA rare pediatric disease designation for spinal muscular atrophy Scholar Rock (NASDAQ:SRRK) received FDA rare pediatric disease designation for SRK-015 for the treatment of spinal muscular atrophy. Spinal muscular atrophy is a rare genetic disease that leads to motor function... August 13, 2020